BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies targeting specific pathogenic bacteria, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback